Blood cancers

SNVs – the more the nastier?

Sponsored by Amgen Australia Pty Ltd

Speaking at the Amgen One conference in Melbourne, Senior Postdoctoral Researcher at the South Australian Health and Medical Research Institute (SAHMRI) Dr Duncan Hewett discussed his team’s work on subclonal heterogeneity and progression in multiple myeloma, noting that single nucleotide variant (SNV) load may not be as important as first thought. Clonal plasma cells have ...

Already a member?

Login to keep reading.

© 2021 the limbic